Please login to the form below

Not currently logged in
Email:
Password:

bribery

This page shows the latest bribery news and features for those working in and with pharma, biotech and healthcare.

Greece steps up Novartis corruption probe after suicide attempt

Greece steps up Novartis corruption probe after suicide attempt

Accelerates investigation into whether Novartis paid bribes to doctors and civil servants to drive sales

Latest news

More from news
Approximately 17 fully matching, plus 57 partially matching documents found.

Latest Intelligence

  • Risky business for pharma Risky business for pharma

    to consider, including but not limited to bribery and corruption, money laundering, competition and antitrust, cybersecurity, data privacy and regulation and compliance. ... posing the most significant risks overall”, perhaps due to continued

  • Stress testing for the perfect compliance storm Stress testing for the perfect compliance storm

    Yet the industry often hits the headlines for all the wrong reasons, with regulators imposing multibillion dollar settlements for compliance failings including corruption and bribery. ... However, EY’s Global Fraud Survey 2016 shows 11% of company

  • Harnessing commercial innovation Harnessing commercial innovation

    However, the situation in China was about to change significantly. Christian took up his China Region post in August 2013, when the full ramifications of the bribery scandal at GlaxoSmithKline had

  • The Heart of the Matter 5 - the only way is ethics The Heart of the Matter 5 - the only way is ethics

    The strengthening of international regulations around anti-bribery – and renewed vigour in their enforcement – has placed pharmaceutical companies under unparalleled scrutiny.

  • The Heart of the Matter 5 - the only way is ethics The Heart of the Matter 5 - the only way is ethics

    The strengthening of international regulations around anti-bribery – and renewed vigour in their enforcement – has placed pharmaceutical companies under unparalleled scrutiny.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • The heart of the matter - Part 5

    How an upsurge in compliance focus, anti-bribery measures and a drive to greater transparency are leading pharma towards partners with demonstrable compliance capability and infrastructure. ... The strengthening of international regulations around

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics